JPMORGAN CHASE & CO - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 37 filers reported holding SPERO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$286
-16.4%
2360.0%0.00%
Q2 2023$3422360.0%0.00%
Q1 2023$02360.0%0.00%
Q4 2022$0
-100.0%
236
-85.1%
0.00%
Q3 2022$3,000
+200.0%
1,588
+24.5%
0.00%
Q2 2022$1,000
-99.9%
1,275
-98.4%
0.00%
Q1 2022$706,000
-54.6%
81,172
-16.5%
0.00%
Q4 2021$1,556,000
-19.5%
97,185
-7.4%
0.00%
Q3 2021$1,932,000
+19.4%
104,934
-9.4%
0.00%
Q2 2021$1,618,000
+60.4%
115,856
+69.0%
0.00%
Q1 2021$1,009,000
-29.4%
68,569
-6.9%
0.00%
Q4 2020$1,429,000
+59.7%
73,675
-18.0%
0.00%
Q3 2020$895,000
-33.7%
89,888
-9.9%
0.00%
Q2 2020$1,349,000
+113.8%
99,775
+27.7%
0.00%
Q1 2020$631,000
-50.7%
78,106
-41.4%
0.00%
Q4 2019$1,281,000
-27.5%
133,278
-20.1%
0.00%
Q3 2019$1,768,000
-3.2%
166,726
+1.4%
0.00%
Q2 2019$1,826,000
-5.3%
164,389
+9.2%
0.00%
Q1 2019$1,929,000
+68.5%
150,575
-19.1%
0.00%
Q4 2018$1,145,000
-38.3%
186,176
+5.5%
0.00%
Q3 2018$1,855,000
-8.8%
176,483
+27.3%
0.00%
Q2 2018$2,034,000
-44.3%
138,643
-45.9%
0.00%
-100.0%
Q1 2018$3,653,000
+24253.3%
256,353
+19604.3%
0.00%
Q4 2017$15,0001,3010.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders